Your browser doesn't support javascript.
loading
[Vascular adverse events of ponatinib during treatment of Philadelphia chromosome-positive leukemia: a retrospective single-institution analysis].
Sato, Nobue; Yuda, Junichiro; Yamauchi, Nobuhiko; Miyamoto, Kenichi; Kamihara, Yusuke; Minami, Yosuke.
Affiliation
  • Sato N; National Cancer Center Hospital East, Pharmaceutical Department.
  • Yuda J; National Cancer Center Hospital East, Department of Hematology and Oncology.
  • Yamauchi N; National Cancer Center Hospital East, Department of Hematology and Oncology.
  • Miyamoto K; National Cancer Center Hospital East, Department of Hematology and Oncology.
  • Kamihara Y; National Cancer Center Hospital East, Department of Hematology and Oncology.
  • Minami Y; National Cancer Center Hospital East, Department of Hematology and Oncology.
Rinsho Ketsueki ; 60(12): 1623-1629, 2019.
Article in Ja | MEDLINE | ID: mdl-31902811
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pyridazines / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Imidazoles / Antineoplastic Agents Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: Ja Journal: Rinsho Ketsueki Year: 2019 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pyridazines / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Imidazoles / Antineoplastic Agents Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: Ja Journal: Rinsho Ketsueki Year: 2019 Type: Article